Gary Clawson
6Patents
2h-index
12Co-inventors
44Inventor score
Filing activity: Nov 8, 1995 → Mar 9, 2005
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6271359A | Tissue-specific and pathogen-specific toxic agents and ribozymes | Chemistry; Metallurgy | 269 | Expired |
| US5824519A | Tissue-specific and target RNA-specific ribozymes | Chemistry; Metallurgy | 24 | Expired |
| US7704965B2 | Methods and materials for treating human papillomavirus infections | Chemistry; Metallurgy | 2 | Expired |
| US7575918B2 | Tissue-specific and pathogen-specific ribozymes | Chemistry; Metallurgy | 1 | Expired |
| US7732197B2 | Tissue-specific and target RNA-specific ribozymes | Emerging Cross-Sectional Technologies | 0 | Expired |
| US7402561B2 | Compositions and methods for inhibiting abnormal cell growth | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.